MedTrace Logo

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

NCT00945555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264

Last updated 2017-04-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to define and classify antibacterial agents used in Turkey for patients with febrile neutropenia.

Conditions

Interventions

DRUG

Antibacterial agent for the treatment of febrile neutropenia

The antibacterial agent used by the investigators for febrile neutropenia will be determined and classified in the preference order

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00945555 on ClinicalTrials.gov